MDxHealth SA (MDXH)

BE — Healthcare Sector
Peers: INZY  DAWN  ABOS  ELDN  ELEV 

Automate Your Wheel Strategy on MDXH

With Tiblio's Option Bot, you can configure your own wheel strategy including MDXH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol MDXH
  • Rev/Share 1.8428
  • Book/Share 0.3037
  • PB 6.9308
  • Debt/Equity 4.0472
  • CurrentRatio 1.568
  • ROIC -0.2252

 

  • MktCap 104191899.0
  • FreeCF/Share -0.4398
  • PFCF -4.8484
  • PE -2.7019
  • Debt/Assets 0.3818
  • DivYield 0
  • ROE -6.9059

 

  • Rating D+
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH)
MDXH
Published: March 06, 2025 by: Zacks Investment Research
Sentiment: Positive

MDxHealth SA (MDXH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Read More
image for news Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH)
MDxHealth SA (MDXH) Q4 2024 Earnings Call Transcript
MDXH
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral

MDxHealth SA (NASDAQ:MDXH ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants John Fraunces - LifeSci Advisors, IR Michael McGarrity - Chief Executive Officer Ron Kalfus - Chief Financial Officer Conference Call Participants Thomas Flaten - Lake Street Andrew Brackmann - William Blair Thomas Vranken - KBC Securities Jason Bednar - Piper Sandler Vidyun Bais - BTIG Dan Brennan - TD Cowen Operator Good day. And welcome to the MDxHealth Fourth Quarter and Full Year 2024 Earnings Call.

Read More
image for news MDxHealth SA (MDXH) Q4 2024 Earnings Call Transcript
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results
MDXH
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral

Fourth quarter revenue growth of 28% to $24.7 million 2024 revenue growth of 28% to $90.0 million 68% improvement in adjusted EBITDA in fourth quarter Conference call with Q&A today at 4:30 PM EST / 22:30 CET

Read More
image for news Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results

About MDxHealth SA (MDXH)

  • IPO Date 2021-11-04
  • Website https://mdxhealth.com
  • Industry Medical - Diagnostics & Research
  • CEO Mr. Michael K. McGarrity
  • Employees 312

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.